Enze Zheng

792 total citations · 1 hit paper
9 papers, 545 citations indexed

About

Enze Zheng is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Enze Zheng has authored 9 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Enze Zheng's work include Cancer, Lipids, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Enze Zheng is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Enze Zheng collaborates with scholars based in China and United Kingdom. Enze Zheng's co-authors include Xiong Z. Ruan, Xiaoqing Luo, Han Zeng, Lei Zhao, Hong Qin, Ping Yang, Yaxi Chen, Wei Li, Yiyu Li and Yaxi Chen and has published in prestigious journals such as Nature Communications, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Enze Zheng

9 papers receiving 541 citations

Hit Papers

CD36-mediated metabolic crosstalk between tumor cells and... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enze Zheng China 7 285 239 147 116 72 9 545
Xiaoqing Luo China 6 281 1.0× 243 1.0× 138 0.9× 116 1.0× 75 1.0× 16 540
Shilpa R. Nagarajan Australia 8 347 1.2× 316 1.3× 97 0.7× 54 0.5× 55 0.8× 14 599
Paula Saavedra-García United Kingdom 13 376 1.3× 148 0.6× 114 0.8× 40 0.3× 57 0.8× 18 531
Faji Yang China 12 187 0.7× 109 0.5× 166 1.1× 57 0.5× 74 1.0× 30 504
Alexander R. Terry United States 10 548 1.9× 425 1.8× 132 0.9× 74 0.6× 90 1.3× 15 852
G Destefanis Italy 3 442 1.6× 333 1.4× 141 1.0× 48 0.4× 89 1.2× 3 703
Fangtian Bu China 18 397 1.4× 239 1.0× 280 1.9× 49 0.4× 38 0.5× 31 722
Salvatore Delogu Germany 6 552 1.9× 384 1.6× 152 1.0× 60 0.5× 108 1.5× 6 846
Dongmei Wang China 13 387 1.4× 322 1.3× 72 0.5× 47 0.4× 47 0.7× 34 626

Countries citing papers authored by Enze Zheng

Since Specialization
Citations

This map shows the geographic impact of Enze Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enze Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enze Zheng more than expected).

Fields of papers citing papers by Enze Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enze Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enze Zheng. The network helps show where Enze Zheng may publish in the future.

Co-authorship network of co-authors of Enze Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Enze Zheng. A scholar is included among the top collaborators of Enze Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enze Zheng. Enze Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Qin, Hong, Xiaoqing Luo, Enze Zheng, et al.. (2024). The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis. Journal of Advanced Research. 74. 237–253. 9 indexed citations
2.
Zheng, Enze, Qianqian Chen, Xiaoqing Luo, et al.. (2024). Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway. Biochemical and Biophysical Research Communications. 707. 149781–149781. 1 indexed citations
3.
Luo, Xiaoqing, Enze Zheng, Yiyu Li, et al.. (2022). Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases. Frontiers in Microbiology. 13. 1039614–1039614. 3 indexed citations
4.
Zeng, Han, Hong Qin, Enze Zheng, et al.. (2022). HIF-2α-induced upregulation of CD36 promotes the development of ccRCC. Experimental Cell Research. 421(2). 113389–113389. 14 indexed citations
5.
Yang, Ping, Hong Qin, Yiyu Li, et al.. (2022). CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nature Communications. 13(1). 5782–5782. 201 indexed citations breakdown →
6.
Yu, Ting, Enze Zheng, Yanping Li, et al.. (2021). Src-mediated Tyr353 phosphorylation of IP3R1 promotes its stability and causes apoptosis in palmitic acid-treated hepatocytes. Experimental Cell Research. 399(2). 112438–112438. 13 indexed citations
7.
Luo, Xiaoqing, Enze Zheng, Wei Li, et al.. (2021). The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis. Cell Death and Disease. 12(4). 328–328. 146 indexed citations
8.
Zeng, Han, Hong Qin, Enze Zheng, et al.. (2021). CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. Molecular Metabolism. 57. 101428–101428. 137 indexed citations
9.
Yang, Ping, Han Zeng, Wei Tan, et al.. (2020). Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR. The FASEB Journal. 34(4). 5658–5672. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026